TNDM — Tandem Diabetes Care Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Tandem Diabetes Care, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	15.6	-94.6	-223	-96	-205
Depreciation
Deferred Taxes
Non-Cash Items	67.6	135	193	115	200
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	14.4	-4.65	-17.7	-11.8	-23
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	111	50.5	-31.8	24.2	-9.72
Capital Expenditures	-23.5	-43	-51.6	-65.6	-19.9
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-163	76.1	-34.1	42.2	92.8
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities	-187	33.2	-85.7	-23.5	72.9
Financing Cash Flow Items	—	-0.675	-0.071	-15.6	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	51.9	16.9	4.11	8.37	-43.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-23.4	101	-114	10.4	21.4